FDA In Brief: FDA takes new steps to broaden patient participation in cancer clinical trials, advancing policies to promote inclusion of pediatric patients and patients with medical conditions that can occur alongside cancer — No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *